Gervasini G - Search Results

1

Variability of the L-Histidine decarboxylase gene in allergic rhinitis.

Gervasini G, Agúndez JA, García-Menaya J, Martínez C, Cordobés C, Ayuso P, Cornejo JA, Blanca M, García-Martín E. Gervasini G, et al. Allergy. 2010 Dec;65(12):1576-84. doi: 10.1111/j.1398-9995.2010.02425.x. Allergy. 2010. PMID: 20608921

2

Tryptamine: a possible endogenous substrate for CYP2D6.

Martínez C, Agúndez JA, Gervasini G, Martín R, Benítez J. Martínez C, et al. Among authors: gervasini g. Pharmacogenetics. 1997 Apr;7(2):85-93. Pharmacogenetics. 1997. PMID: 9170145

3

Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine.

Agúndez JA, Gallardo L, Martínez C, Gervasini G, Benítez J. Agúndez JA, et al. Among authors: gervasini g. Pharmacogenetics. 1998 Jun;8(3):251-8. Pharmacogenetics. 1998. PMID: 9682270

4

Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors.

Martínez C, Gervasini G, Agúndez JA, Carrillo JA, Ramos SI, García-Gamito FJ, Gallardo L, Benítez J. Martínez C, et al. Among authors: gervasini g. Eur J Clin Pharmacol. 2000 May;56(2):145-51. doi: 10.1007/s002280050733. Eur J Clin Pharmacol. 2000. PMID: 10877009

5

Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline.

Gervasini G, Martínez C, Agúndez JA, García-Gamito FJ, Benítez J. Gervasini G, et al. Pharmacogenetics. 2001 Feb;11(1):29-37. doi: 10.1097/00008571-200102000-00004. Pharmacogenetics. 2001. PMID: 11207028

6

Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients.

Gervasini G, García-Martín E, Ladero JM, Pizarro R, Sastre J, Martínez C, García M, Diaz-Rubio M, Agúndez JA. Gervasini G, et al. BMC Cancer. 2007 Jul 2;7:118. doi: 10.1186/1471-2407-7-118. BMC Cancer. 2007. PMID: 17605821 Free PMC article.

7

Effect of common NAT2 variant alleles in the acetylation of the major clonazepam metabolite, 7-aminoclonazepam.

Olivera M, Martínez C, Gervasini G, Carrillo JA, Ramos S, Benítez J, García-Martin E, Agúndez JA. Olivera M, et al. Among authors: gervasini g. Drug Metab Lett. 2007 Jan;1(1):3-5. doi: 10.2174/187231207779814283. Drug Metab Lett. 2007. PMID: 19356010

8

Effect of neurotransmitters on NADPH-cytochrome P450 reductase in vitro activity.

Gervasini G, Martinez C, Benitez J, Agúndez JA. Gervasini G, et al. Drug Metab Lett. 2007 Aug;1(3):172-5. doi: 10.2174/187231207781369762. Drug Metab Lett. 2007. PMID: 19356039

9

CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk.

Gervasini G, de Murillo SG, Ladero JM, Agúndez JA. Gervasini G, et al. Pharmacogenomics. 2010 Jul;11(7):919-25. doi: 10.2217/pgs.10.66. Pharmacogenomics. 2010. PMID: 20602611

10

Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain.

Agúndez JA, Abad-Santos F, Aldea A, Alonso-Navarro H, Bernal ML, Borobia AM, Borrás E, Carballo M, Carvajal A, García-Muñiz JD, Gervasini G, Jiménez-Jiménez FJ, Lucena MI, Martínez C, Sacristán JA, Salado I, Sinués B, Vicente J, García-Martín E. Agúndez JA, et al. Among authors: gervasini g. Front Genet. 2012 Nov 26;3:273. doi: 10.3389/fgene.2012.00273. eCollection 2012. Front Genet. 2012. PMID: 23233861 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters